olivLaw · European equity research
Prosus N.V. PRX.AS
Netherlands · Euronext Amsterdam · ISIN NL0013654783 · Vertical: Listed companies from Netherlands
At the close of 06 Nov 2026, Prosus N.V. (PRX.AS) stock was 37.56 EUR (−1.22% on the day), with beta 1.02, 52-week range 33.93–62.18 EUR.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 64.7
- strong (55–70)
- Bollinger (20, 2)
- 33.08 – 37.67
- in the upper half of the band · %B 0.97 · band width 13.0%
- SMA 50 / 200
- 35.76 / 39.63
- mixed trend
- MACD (12, 26, 9)
- 0.24 / -0.18
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +6.4% | −0.2% | +6.5 pp | — |
| 3 months | −11.6% | −5.4% | −6.2 pp | — |
| 6 months | −8.4% | +4.4% | −12.8 pp | — |
| Year to date | −28.9% | +6.5% | −35.4 pp | — |
| 1 year | −37.7% | +10.0% | −47.7 pp | −2.4% |
| 3 years | +31.4% | +48.6% | −17.2 pp | +0.3% |
| 5 years | +12.3% | +41.4% | −29.2 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
the price (USD) and the reports are in different currencies
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 5.2 bn | 4.9 bn | 5.5 bn |
| Revenue YoY | unavailable | −5.2% | +10.5% |
| Net income | 18.7 bn | 10.1 bn | 6.6 bn |
| Net income YoY | unavailable | −46.0% | −34.7% |
| Diluted EPS | 12.32 | 3.63 | 2.53 |
| Diluted EPS YoY | unavailable | −70.5% | −30.3% |
| net % | 358.9% | 204.4% | 120.8% |
| Free cash flow | -817.0 m | -349.0 m | 1.0 bn |
Balance sheet & financial health
Fiscal year 2024 · 31 Mar 2024
- Cash
- 2.2 bn USD
- Financial debt
- 16.2 bn USD
- Net debt
- 14.0 bn USD
- Equity
- 41.3 bn USD
- Total assets
- 61.8 bn USD
- Debt / equity
- 0.39x
- Current ratio
- 4.77x
- ROE
- 15.4%
- ROA
- 10.4%
- FCF margin
- 18.3%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 5.2 bn | 4.9 bn | 5.5 bn | esef· 04 Jul 2024verified |
| Cost of revenue | 3.8 bn | 3.3 bn | 3.2 bn | esef· 04 Jul 2024verified |
| Gross profit | 1.4 bn ≈ | 1.6 bn ≈ | 2.2 bn ≈ | esef· 04 Jul 2024derived |
| Operating income | -950.0 m | -1.0 bn | -546.0 m | esef· 04 Jul 2024verified |
| Interest expense | 398.0 m | 555.0 m | — | esef· 28 Jun 2023verified |
| Pre-tax income | 18.6 bn | 9.8 bn | 7.0 bn | esef· 04 Jul 2024verified |
| Income tax | 54.0 m | 42.0 m | 161.0 m | esef· 04 Jul 2024verified |
| Net income | 18.7 bn | 10.1 bn | 6.6 bn | esef· 04 Jul 2024verified |
| Diluted EPS | 12.32 | 3.63 | 2.53 | esef· 04 Jul 2024verified |
| Dividend per share | 0.14 | 0.14 | 0.07 | esef· 04 Jul 2024verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue.
Balance sheet · USD
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Cash | 9.6 bn | 9.6 bn | 2.2 bn | esef· 04 Jul 2024verified |
| Inventories | 470.0 m | 324.0 m | 268.0 m | esef· 04 Jul 2024verified |
| Current assets | 15.3 bn | 23.4 bn | 22.1 bn | esef· 04 Jul 2024verified |
| Property, plant & equipment, net | 604.0 m | 620.0 m | 555.0 m | esef· 04 Jul 2024verified |
| Goodwill | 3.4 bn | 1.4 bn | 1.0 bn | esef· 04 Jul 2024verified |
| Intangibles (excl. goodwill) | 928.0 m | 367.0 m | 326.0 m | esef· 04 Jul 2024verified |
| Total assets | 71.3 bn | 65.1 bn | 61.8 bn | esef· 04 Jul 2024verified |
| Accounts payable | 549.0 m | 356.0 m | 365.0 m | esef· 04 Jul 2024verified |
| Short-term debt | 312.0 m | 467.0 m | 472.0 m | esef· 04 Jul 2024verified |
| Long-term debt | 15.9 bn | 15.8 bn | 15.7 bn | esef· 04 Jul 2024verified |
| Current liabilities | 4.4 bn | 4.4 bn | 4.6 bn | esef· 04 Jul 2024verified |
| Equity | 50.5 bn | 44.6 bn | 41.3 bn | esef· 04 Jul 2024verified |
| Shares outstanding at year end | 1.5 bn | 2.7 bn | 2.6 bn | esef· 04 Jul 2024derived |
Cash flow · USD
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | -605.0 m | -120.0 m | 1.0 bn | esef· 04 Jul 2024verified |
| Capex | 212.0 m | 229.0 m | 42.0 m | esef· 04 Jul 2024verified |
| Free cash flow | -817.0 m ≈ | -349.0 m ≈ | 1.0 bn ≈ | esef· 04 Jul 2024derived |
| Investing cash flow | 4.4 bn | 12.6 bn | 209.0 m | esef· 04 Jul 2024verified |
| Financing cash flow | 2.4 bn | -12.5 bn | -8.1 bn | esef· 04 Jul 2024verified |
| Dividends paid | 238.0 m | 191.0 m | 199.0 m | esef· 04 Jul 2024verified |
| Share repurchases | 5.0 bn | 9.9 bn | 7.3 bn | esef· 04 Jul 2024verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 37.5% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
06 Nov 2026Source: olivLaw, closing series
Market cap: unavailable
Price and reporting are in different currencies; market indicators are unavailable.
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
38% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 26.64 – 64.02 USD.
Methods computed but outside the aggregate range: Dividend discount (DDM) (a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate).
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E26.64 – 64.02 (Mid 36.46)16 companies used · median multiple 14.4x · quartiles 10.5x – 25.3xAALB.AS, ACOMO.AS, AD.AS, ADYEN.AS, AKZA.AS, ARCAD.AS, ASM.AS, ASML.AS, AXS.AS, BAMNB.AS, BNJ.AS, CRBN.AS, CTAC.AS, ECMPA.AS, FFARM.AS, HAL.AS
- Dividend discount (DDM)outside the aggregate0.92 – 1.24 (Mid 1.06)a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 37.5% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | -1.0% | 31 (vs peers) | 28% |
| Net margin · Quality | 120.8% | 97 (vs peers) | 17% |
| FCF conversion · Quality | 15.2% | 0 (on a fixed band) | 17% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -1.0x | 0 (on a fixed band) | 17% |
| Current ratio · Balance sheet | 4.8x | 100 (on a fixed band) | 11% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | 19.8% | 100 (on a fixed band) | 11% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality41/100 · 3/3 factors with a value
- Returns· partial100/100 · 1/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Prosus N.V. (PRX.AS). Latest full fiscal year: 2024; data up to 2024-03-31.
Figures computed from the financial statements: revenue 5.5 bn USD in 2024; YoY growth 10.5%; net margin 120.8%; ROE 15.4%.
The estimated value range is 26.64–64.02 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 37.5% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 120.8%
- Current ratio: 4.8x
- Payout ratio (FCF): 19.8%
What contradicts it
- FCF conversion: 15.2%
- Interest coverage: -1.0x
Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions).
Versus the vertical median
Listed companies from Netherlands · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ASML.ASASML Holding N.V. | 498.6 bn | 48.9 | 44.2% | 31.3% | +15.6% | +42% / +106% |
| DSFIR.ASDSM-Firmenich AG | 32.7 bn | 116.8 | 1.2% | 2.2% | +20.4% | +55% / +26% |
| ASM.ASASM International N.V. | 31.9 bn | 44.3 | 18.7% | 22.8% | +8.2% | +37% / +38% |
| AD.ASKoninklijke Ahold Delhaize N.V. | 30.9 bn | 13.7 | 15.3% | 2.5% | +3.4% | −4% / +29% |
| ADYEN.ASAdyen N.V. | 28.4 bn | 26.8 | 22.3% | 40.1% | +18.9% | −33% / −16% |
| HAL.ASHAL Trust | 15.3 bn | 9.6 | 10.5% | 12.8% | +1.2% | +21% / +46% |
| EXO.ASExor N.V. | 15.1 bn | — | -10.6% | — | −100.0% | +1% / −18% |
| BESI.ASBE Semiconductor Industries N.V. | 11.4 bn | 86.4 | 28.7% | 22.3% | −2.7% | +10% / +12% |
| AKZA.ASAkzo Nobel N.V. | 10.8 bn | 17.0 | 13.8% | 6.3% | −5.2% | +12% / −11% |
| AALB.ASAalberts N.V. | 4.4 bn | 24.8 | 7.2% | 5.7% | −5.3% | +45% / +11% |
| ARCAD.ASArcadis N.V. | 4.1 bn | 19.8 | 18.3% | 4.3% | −2.4% | +21% / +0% |
| BNJ.ASBanijay Group N.V. | 3.4 bn | 13.8 | 343.8% | 5.1% | +1.6% | −11% / −8% |
| BAMNB.ASKoninklijke BAM Groep N.V. | 3.3 bn | 42.0 | 9.1% | 1.3% | +2.9% | +47% / +403% |
| BFIT.ASBasic-Fit N.V. | 2.0 bn | 137.1 | 3.6% | 1.0% | +16.9% | +6% / +15% |
| CRBN.ASCorbion N.V. | 1.6 bn | 8.3 | 27.3% | 14.9% | +1.9% | +39% / +55% |
| ECMPA.ASEurocommercial Properties N.V. | 1.4 bn | 11.2 | 5.9% | 45.4% | +4.2% | −4% / +19% |
| FUR.ASFugro N.V. | 963.7 m | — | -1.5% | -1.1% | −18.8% | −2% / −50% |
| ACOMO.ASAcomo N.V. | 681.5 m | 15.1 | 10.7% | 3.3% | +7.6% | −4% / +36% |
| FAST.ASFastned B.V. | 671.8 m | — | -28.2% | -21.7% | +66.1% | +62% / +26% |
| FFARM.ASForFarmers N.V. | 477.6 m | 9.6 | 14.5% | 1.6% | +14.8% | +21% / +122% |
| BRNL.ASBrunel International N.V. | 356.7 m | 116.8 | 1.0% | 0.3% | −10.8% | −12% / −34% |
| ALFEN.ASAlfen N.V. | 222.6 m | — | -0.1% | -0.0% | −10.7% | −3% / −78% |
| ENVI.ASEnvipco Holding N.V. | 219.9 m | — | -12.7% | -11.9% | −20.8% | −27% / +44% |
| CMCOM.ASCM.com N.V. | 192.5 m | — | -22.2% | -1.5% | −5.4% | +23% / −30% |
| AJAX.ASAFC Ajax N.V. | 141.7 m | — | -18.0% | -21.0% | +17.2% | −15% / −29% |
1- and 3-year price returns: for PRX.AS from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202404 Jul 2024
- Annual report 202328 Jun 2023
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.